Hill Dermaceuticals, Inc.August 11, 2021

FDA 483 - Hill Dermaceuticals, Inc. - August 11, 2021

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hill Dermaceuticals, Inc.

Record Details

Hill Dermaceuticals, Inc. in Sanford, FL, a drug manufacturer, was inspected and received a Form 483 with four observations. The inspection revealed significant issues with facility maintenance, including peeling paint and holes, a lack of hot water in restrooms, and critical failures in microbiological testing for raw materials and finished products. Additionally, the firm failed to follow written production procedures, specifically regarding personnel hygiene during manufacturing.

Company: Hill Dermaceuticals, Inc.
Inspection Date: August 11, 2021
Product Type: Drugs
Office: Office of Medical Device and Radiological Health Division II
People: Steven A. Brettler (Consumer Safety Officer)
Nicole E. Knowlton (Investigator )

Open in Dashboard

ID · 03ee59a5-26b6-4687-8270-ec345acd064b